Studi Kasus
Studi Kasus
Urinalisis
Color yellow; turbidity clear; SG 1.010; pH 7.2; glucose >1,000 mg/ dL; bilirubin (–); ketones (–); Hgb (–); protein
(–); nitrite (–); crystals (–); casts (–); mucous (–); bacteria (–); urobilinogen: 0.25 EU/dL; WBC 0–5/hpf; RBC
0/hpf; epithelial cells: 0–10/hpf
Abdominal USG : Non-specific gas pattern; no dilated bowel. Questionable opacity/ abnormality of common bile
duct. Cannot rule out gallstone/ obstruction.
Assasement : Acute pancreatitis precipitating hyperglycemia, hypocalcemia, and non-anion gap metabolic
acidosis, R/O choledocholithiasis
Question :
a. What factors may have precipitated acute pancreatitis in this case?
b. What signs, symptoms, and laboratory tests are consistent with the diagnosis of acute pancreatitis?
c. What are the goals of therapy for this patient?
d. What parameter should be monitor ?
Case B
Chief Complaint : ““I’m here for my yearly visit, I’m not sick!”
HPI (History of present illness) : Ima Ferguson is a 56-year-old woman who presents to the clinic for her yearly
follow-up. The patient states that she feels fine and has been in her usual state of health since last clinic visit.
She also states she is not sure why she has to come to clinic every year, indicating; “There is nothing wrong with
me.” The patient’s former primary care provider has transferred to a different facility
Present Medication History : Morbid obesity (BMI 35.6 kg/m2), HTN for 24 years, IFG diagnosed 1 year ago
Osteoarthritis bilateral knees, Leg cramping >three blocks walking, Seasonal rhinitis since childhood
Perimenopausal—has OB/GYN screening yearly
Family History : Father; age 71 with Type 2 diabetes, COPD, hypertension
Mother; age 71 with advanced Parkinson’s, “heart disease” diagnosed at age 66
Patient does not have contact with her two younger brothers, their medical history is unknown Of her children, the
only significant medical history is one daughter with epilepsy.
Social history : Patient is a widow; she has four adult children, one of whom lives with her in her home along
with his three children Completed the 9th grade and provides day-care in her home. Denies alcohol, tobacco, or
illicit drug use.
Medication history : Enalapril 10 mg po BID, OTC potassium gluconate 595 mg po PRN for leg cramps,
Diphenhydramine 25–50 mg po PRN rhinitis, Ibuprofen 200 mg, 4 tabs po PRN HA, knee pain
Review of system : Patient states that she is in her normal state of health. She denies unilateral weakness,
numbness/tingling, or acute changes in vision (although over the course of the past year her vision prescription
has changed twice). She additionally denies CP, SOB, changes in bowel habits, or po intake. She states that she
has noticed more frequent leg cramps that begin after walking shorter distances than usual. In the past she was
able to walk ~6 blocks without pain, but now she gets cramping/pain walking just 2–3 blocks. She has also
noticed some swelling of the lower legs and feet, especially at the end of the day and has had increasingly
severe AM knee pain over the past several months. She admits to taking ibuprofen most days of the week.
Physical Examination :
General : Obese Caucasian woman in NAD
VS : BP 147/92, HR 83, RR 16, T 37.2°C; Wt 97 kg, Ht 5'5''
Skin : Warm and moist, normal turgor, acanthosis nigricans noted in axilla bilaterally
Lab test :
Na 142 mEq/L Ca 8.6 mg/dL WBC 5.3 × 103/mm3 Lipid Profile:
K 4.9 mEq/L Mg 2.1 mEq/L Hemoglobin 11.5 g/dL TC 259 mg/dL
Cl 104 mEq/L AST 34 U/L Hematocrit 34.6% HDL 37 mg/dL
CO2 24 mEq/L ALT 31 U/L Platelets 151 × 103/mm3 LDL 167 mg/dL
BUN 21 mg/dL T. bili 0.5 mg/dL TG 280 mg/dL
SCr 1.3 mg/dL T. prot 7.1 g/dL
Glucose 121 mg/dL
Urinalisis :
Yellow, clear, SG 1.003, pH 5.3, (–) protein, (–) glucose, (–) ketones, (–) bilirubin, (–) blood, (–) nitrites, RBC
0/hpf, WBC 1/hpf, no bacteria, 1–5 epithelial cells
Assasement :
Ms. Ferguson is an obese woman who presents to primary care clinic for her yearly exam. Patient has OA and
seasonal rhinitis, both of which she self-treats with OTC medications. She also has uncontrolled HTN, which is
currently treated with an ACE inhibitor. IFG was diagnosed last year. Patient has new onset anemia,
hyperlipidemia, renal insufficiency, and symptoms suggestive of possible PAD. When questioned about exercise
and dietary habits, the patient immediately became very defensive about her weight and stated that she is just
“big boned” and has a “slow metabolism.”
Question ;
a. What drug-related problems does this patient have?
b. What laboratory values indicate the presence and severity of hyperlipidemia in this patient?
c. This patient has been diagnosed with hyperlipidemia. What are her risk factors (both modifiable and non-
modifiable) for CV disease?
d. What is this patient’s risk classification for cardiovascular disease, and how does this relate to her individual
lipid goals?